A Phase 1, Open Label, Multiple Center Study to Evaluate the Pharmacokinetics of Once-Daily CLS001 Topical Gel Under Maximal Use Conditions Administered for 21 Days in Subjects With Papulopustular Rosacea
Latest Information Update: 14 Jun 2019
Price :
$35 *
At a glance
- Drugs Omiganan (Primary)
- Indications Rosacea
- Focus Pharmacokinetics
- Sponsors Cutanea Life Sciences
- 11 Apr 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 13 Jan 2014 New trial record